Pineapple Financial launches a $100M INJ treasury, making Injective’s token Wall Street-ready and boosting its role in tokenized assets.
Author: Akshay
Pineapple Financial Inc. (NYSE: PAPL) has announced the creation of a $100 million INJ treasury. The initiative was revealed during Sonic Summit 2025 in Singapore and marks the first time Wall Street gains access to Injective (INJ) through a publicly traded company.
This allocation makes Pineapple the largest institutional holder of INJ. Backed by prominent investors including FalconX, Kraken, and Blockchain.com, the INJ treasury will be deployed gradually over the coming months to support tokenized asset adoption.
Injective began as a decentralized exchange protocol in 2018 and evolved into a finance-focused Layer-1 blockchain. Its ecosystem gained significant momentum in 2025, particularly after Google Cloud became a validator.
Pineapple’s INJ treasury builds on this momentum. The $100 million allocation equals around 10% of INJ’s $1 billion market cap. Such a large-scale purchase could influence price trends, liquidity, and volatility. Analysts also highlight the potential for ETF or ETP eligibility, which could channel billions of dollars in institutional capital into Injective.
The launch represents more than a short-term market event. By 2030, Pineapple’s INJ treasury may accelerate Wall Street’s entry into altcoins, with Injective at the forefront of tokenized real-world assets. McKinsey projects the RWA market could reach $2 trillion, and Injective is now strategically positioned to capture that growth.
Over time, this treasury could encourage stronger regulatory frameworks, fuel DeFi innovation, and position INJ as a cornerstone asset bridging traditional finance and decentralized ecosystems.
Our Crypto Talk is committed to unbiased, transparent, and true reporting to the best of our knowledge. This news article aims to provide accurate information in a timely manner. However, we advise the readers to verify facts independently and consult a professional before making any decisions based on the content since our sources could be wrong too. Check our Terms and conditions for more info.
